MIRA
INFORM REPORT
|
Report Date : |
05.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
MULTILAB INDÚSTRIA E COMÉRCIO DE PRODUTOS FARMACÊUTICOS LTDA |
|
|
|
|
Registered Office : |
RS 401 Km 30 Nº 1.009 – Centro, 96700-000 – São Jerônimo/RS - |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
2007 |
|
|
|
|
Date of Incorporation : |
15.06.1988 |
|
|
|
|
Com. Reg. No.: |
43.201.555.072 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Industry of pharmaceutical products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Head information
Company name : MULTILAB
INDÚSTRIA E COMÉRCIO DE PRODUTOS FARMACÊUTICOS LTDA
Trade Name :
MULTILAB
Economical Group : GENESIO
CERVO
Address : RS
401 Km 30 Nº 1.009 – Centro, 96700-000 – São Jerônimo/RS - Brasil
Phone :
(55-51) 3510-1971 / 3651-1884
Fax :
(55-51) 3223-6198
E-mail : multilab@multilabsj.com.br
Web Site : www.multilab.com.br
Legal information
Legal Status :
Private Limited Company
Incorporation date : June
15,, 1988
Register number :
43.201.555.072
Tax contributor (CNPJ) :
92.265.552/0001-40
Registered capital :
R$2.600.000,00
State Registration # :
121/0050568
Number of employees : 402
Commercial department : Rua
Mariano de Matos, 734 – Bairro Medianeira, 90880-250 – Porto Alegre/RS – Brasil
History
Established on June 15, 1988, chartered at the State Commerce
Registration Office of Rio Grande do Sul (JUCERS) under # 43.201.555.072, with
the registered name of Multilab Indústria e Comércio Ltda. On August 01, 1988
the subject changed to the present registered name.
Partnership:
Genésio Cervo (joined
06/1988) - 85,0%
Brazilian, CPF: 140.389.860-04
Rejane Terezinha Gobbi (joined
05/1994) - 15,0%
Brazilian, CPF: 503.542.130-91
Management:
Genésio Cervo -
Shareholder Director
Brazilian, Separated judicially, CPF: 140.389.860-04
Properties
Own building.
Registered line of business:
Industry of pharmaceutical products
Purchases
70% - Domestic market
30% - International market
Sales:
100% - Domestic market
Related Companies
Stock participation:
CERVOSUL DISTRIB.DE MEDICAMENTOS LTDA -
CNPJ: 89.543.078/0001-66
- Genésio Cervo -
85,0%
- Rejane Terezinha Gobbi -
15,0%
Financial Data
According to the Brazilian Law Private Limited Companies are not obliged
to file financial accounts for public inspection.
The following financial statement was obtained through outside sources
consulted.
Quarterly balance sheet as of 30/06/2007 – US$1.00 = R$1,926
Balance sheet information for fiscal year ending:
31/12/2006 – US$1.00 = R$2,138
31/12/2005 – US$1.00 = R$2,341
Figures are in (Thousands of) Reais R$:
|
Assets |
06/2007 |
03/2006 |
2005 |
|
Current Assets |
38.348 |
31.623 |
28.006 |
|
Account Receivable |
19.615 |
15.676 |
11.122 |
|
Inventory |
14.310 |
12.888 |
10.578 |
|
Other Assets |
4.423 |
3.059 |
6.306 |
|
Long Term Assets |
7.176 |
8.326 |
459 |
|
Fixed Assets |
27.541 |
25.167 |
19.507 |
|
Investment |
4.975 |
5.758 |
3.391 |
|
Immovable |
20.780 |
19.409 |
16.116 |
|
Total Assets |
73.065 |
65.116 |
47.972 |
|
Liabilities |
06/2007 |
2006 |
2005 |
|
Current Liabilities |
25.105 |
26.585 |
17.377 |
|
Suppliers |
5.258 |
8.106 |
5.333 |
|
Other liabilities |
19.847 |
18.479 |
12.044 |
|
Long Term
Liabilities |
11.470 |
7.583 |
7.670 |
|
Net Equity |
36.490 |
30.948 |
22.925 |
|
Capital |
2.600 |
2.600 |
2.600 |
|
Reserves |
9.300 |
9.205 |
5.502 |
|
Accumulated Profit (Loss) |
24.590 |
19.143 |
14.823 |
|
Total Liabilities |
73.065 |
65.116 |
47.972 |
|
Income Statement |
06/2007 |
2006 |
2005 |
|
Annual Net Sales |
37.957 |
66.343 |
42.453 |
|
Gross Income |
15.164 |
15.674 |
14.077 |
|
Operating Income |
9.042 |
8.002 |
6.838 |
|
Net Income |
6.254 |
5.837 |
5.059 |
|
Financial Analysis |
06/2007 |
2006 |
2005 |
|
Current Ratio |
1,52 |
1,18 |
1,61 |
|
Current Debt
Ratio |
0,68 |
0,85 |
0,75 |
|
Total Debt Ratio |
2,00 |
2,10 |
2,09 |
|
Working Capital |
$13.243 |
$5.038 |
$10.629 |
(Dollar rate US$1.00 = R$1,757 on
03/01/2008).
Banking
Banco do Estado do Rio Grande do Sul S/A. - branch 0047
Banco Santander Meridional S/A. -
branch 0503
Banco Bradesco S/A. -
branch 3143
Banco do Brasil S/A. -
branch 3418
Banco safra S/A. -
branch 0007
Remark
Banking comments could not be obtained due to legal restrictions from
the Brazilian Law.
Up to January 03, 2008 no returned cheques were found either in the name
of the company or partners.
Insurance
Not informed.
Payment information
725- Invoices
Information
on purchases:
JAN/2008 Last: R$164 Average: R$4.329
Information
on invoicing:
JUL/2007 Highest: R$242.620 Average: R$16.840
Information
on accumulation:
AUG/2007 Highest: R$257.933 Average: R$23.034
100% - Prompt payments
Trade References
Main Suppliers:
Almapal S/A
Florestal Alimentos S/A
Gráfica Litocromart Ltda.
Vedat Tampas Herméticas Ltda.
Braskap Indústria e Comércio S/A
Companhia Industrial de Vidros - CIV
Wheaton do Brasil Indústria e Comércio ltda
Main clients:
Pro Diet Farmacêutica Ltda.
Valter Lupércio Ferreira & Cia Ltda
Comercial Cirúrgica Rioclarense Ltda.
Buarque Comércio e Representações Ltda
Distribuidora Navarro de Medicamentos Ltda.
Cervosul Distribuidora de Medicamentos Ltda.
Public Information
Up to January 03, 2008, no negative information was found.
Remarks
The information in this report were obtained from outside sources and
public records consulted.
Final Opinion
Based on overall information, the company can be considered normal for business
dealings at usual trade terms and conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)